What is Precigen's total?

Precigen (PGEN) reported total of $49.27M in Q1 2026.

How has Precigen's total changed year-over-year?

Precigen's total decreased by 34.2% year-over-year, from $74.92M to $49.27M.

What is the long-term trend for Precigen's total?

Over 5 years (2020 to 2025), Precigen's total has grown at a 7.7% compound annual growth rate (CAGR), from $48.31M to $70.13M.

Precigen PGEN Total

Total at other companies

Regeneron PharmaceuticalsREGN

——

Viridian Therapeutics, Inc.VRDN

——

Agios PharmaceuticalsAGIO

——

BridgeBio PharmaBBIO

——

AmgenAMGN

——

Merck & Co.MRK

——

Other financials

Income statement

See full

Revenue$23.3M+1,634%

Operating income-$6.0M+73.5%

Net income-$7.9M+85.4%

EPS (diluted)-$0.02+88.9%

Balance sheet

See full

Cash & equivalents$7.5M+23.5%

Total debt$98.3M+1,714%

Total equity$20.2M+244%

Total assets$138.6M+7.6%

Cash flow

See full

Operating cash flow-$43.8M-168%

CapEx$258.0K-58.5%

Free cash flow-$44.1M-160%

Valuation

See full

Market cap$1.93B+213%

Profitability

See full

Gross margin83.6%—

Operating margin-2,890.9%—

Net margin-3,656%—

FCF margin-1,756.5%—

Returns & leverage

See full

Return on equity-843.6%-1,103pp

Debt / equity4.9×—

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Precigen's total?: Precigen (PGEN) reported total of $49.27M in Q1 2026.
How has Precigen's total changed year-over-year?: Precigen's total decreased by 34.2% year-over-year, from $74.92M to $49.27M.
What is the long-term trend for Precigen's total?: Over 5 years (2020 to 2025), Precigen's total has grown at a 7.7% compound annual growth rate (CAGR), from $48.31M to $70.13M.